# Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment

> **NCT01227369** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 4376 (actual)

## Conditions studied

- Osteoporosis, Postmenopausal

## Interventions

- **OTHER:** OPSAT-Q

## Key facts

- **NCT ID:** NCT01227369
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 4376 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01227369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01227369, "Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01227369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*